Publication: 2191

Repeated Measures Analyses of Dermatitis Symptom Evolution in Breast Cancer Patients Receiving Radiotherapy in a Phase 3 Randomized Trial of Mometasone Furoate vs Placebo (N06C4 [Alliance])
      QxMD      Google Scholar   
Citation:
Support Care Cancer vol 24 (9) 3847-3855
Year:
2016
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA035267, U10 CA052352, U10 CA037417, N01 CA035431, U10 CA035269, K05 CA124477, U10 CA031946, U10 CA033601, U10 CA037404, N01 CA035119, U10 CA063848, U10 CA035195, U10 CA035101, UG1 CA189823, U10 CA035113, U10 CA035415, U10 CA063849, U10 CA035431, U10 CA035119, U10 CA180867, U10 CA025224  
Corr. Author:
 
Authors:
                                   
Networks:
CARLE, IWORC, KS055, LAPS-MN026, METROMIN, OH016, UPSTATE   
Study
NCCTG-N06C4
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
breast cancer, clinical trials, quality of life, radiation, radiation oncology